Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease-Reference-Cited by-同舟云学术

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Published:2020-12 Issue:S9 Volume:16 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Haeberlein Samantha Budd¹,von Hehn Christian¹,Tian Ying¹,Chalkias Spyros¹,Muralidharan Kumar Kandadi¹,Chen Tianle¹,Wu Shuang¹,Skordos LeAnne¹,Nisenbaum Laura¹,Rajagovindan Raj¹,Dent Gersham¹,Harrison Katie¹,Nestorov Ivan¹,Zhu Ying¹,Mallinckrodt Craig¹,Sandrock Alfred¹

Affiliation:

1. Biogen Cambridge MA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.047259

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease: A Systematic Review and Meta-Analysis;Cureus;2024-08-28

2. Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond;Journal of Clinical Medicine;2024-05-25

3. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies;Medicinal Research Reviews;2024-03-26

4. New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-01

5. Alzheimer’s Disease and Other Dementias;Geriatric Medicine;2024